Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignancies.

Sato, Takahiko; Kawashima, Naomi; Ito, Masafumi; Atsuta, Yoshiko; Kagaya, Yusuke; Seto, Aika; Morishita, Takanobu; Fukushima, Nobuaki; Ozawa, Yukiyasu; Miyamura, Koichi

Sato, Takahiko; Kawashima, Naomi; Ito, Masafumi; Atsuta, Yoshiko; Kagaya, Yusuke; Seto, Aika; Morishita, Takanobu; Fukushima, Nobuaki; Ozawa, Yukiyasu; Miyamura, Koichi.

Afiliación

Sato T; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Kawashima N; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Ito M; Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
Kagaya Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Seto A; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Morishita T; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Fukushima N; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Miyamura K; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.

Blood Cell Ther ; 3(4): 84-91, 2020 Nov 25.

Article en En | MEDLINE | ID: mdl-36711006

Palabras clave

allogeneic hematopoietic stem cell transplantation; bone marrow pathology; minimal residual disease; myeloid malignancies; relapse

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Cell Ther Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google